Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Abrishami A et al. – Sugammadex is a new medication that is used after surgery in order to reverse the effects of muscle relaxation medications. In this review article we have included 18 trials on the efficacy and safety of sugammadex. The trials included a total of 1321 patients. Sugammadex was shown to be effective in reversing rocuronium–induced neuromuscular blockade. This review has found no evidence of a difference in the instance of unwanted effects between sugammadex, placebo or neostigmine. These results need to be confirmed by future trials on larger patient populations and with more focus on patient–related outcomes.

Related Articles

Sugammadex: a guide to its use in anaesthetic practice
Drugs & Therapy Perspectives, 10/16/09    Relevance Score: 79%

Reversal of Neuromuscular Blockade: Current Concepts & Future Developments
Journal of Anaesthesiology Clinical Pharmacology, 10/12/09    Relevance Score: 66%

Sugammadex: the first selective binding reversal agent for neuromuscular block
Journal of Clinical Anesthesia, 10/19/09    Relevance Score: 65%

High frequency jet ventilation through a supraglottic airway device: a case series of patients undergoing extra-corporeal shock wave lithotripsy
Anaesthesia, 11/10/09    Relevance Score: 64%

The bispectral index and suppression ratio are very early predictors of neurological outcome during therapeutic hypothermia after cardiac arrest
Intensive Care Medicine, 10/28/09    Relevance Score: 64%

Today in Other Drugs...keeping you current

Does Simvastatin Cause More Myotoxicity Compared with Other Statins
Annals of Pharmacotherapy, 12/03/09

Myxedema Coma Associated with Combination Aripiprazole and Sertraline Therapy
Annals of Pharmacotherapy, 12/03/09

Factors Associated with Multiple Medication Use in Different Age Groups
Annals of Pharmacotherapy, 12/03/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address